tiprankstipranks
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market

Acro Biomedical Co (ACBM) Income Statement

10 Followers

Acro Biomedical Co Income Statement

Last quarter (Q ), Acro Biomedical Co's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Acro Biomedical Co's net income was $-3.19M. See Acro Biomedical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Sep 19Sep 18
Total Revenue
-$ 1.20M-$ 193.54K$ 1.35M$ 8.01M
Cost of Revenue
--$ 528.56K$ 181.44K$ 1.22M$ 7.18M
Gross Profit
-$ 1.20M$ -528.56K$ 12.10K$ 135.40K$ 833.40K
Operating Expense
$ 15.21M$ 8.89M$ 289.87K$ 434.85K$ 576.95K$ 317.85K
Operating Income
$ -15.20M$ -7.69M$ -818.43K$ -422.75K$ -441.55K$ 515.55K
Net Non Operating Interest Income Expense
$ -710.00$ -4.25K$ -5.08K$ -1.98K$ -2.27K$ -3.66K
Other Income Expense
-$ 938.00K$ -687.96K---
Pretax Income
$ -15.21M$ -7.70M$ -135.54K$ -424.73K$ -443.82K$ 511.89K
Tax Provision
--$ -18.09K$ -53.13K$ -73.07K$ 92.23K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -15.21M$ -7.70M$ -117.45K$ -371.60K$ -370.75K$ 419.66K
Basic EPS
$ -0.07$ -0.14-$ -0.01$ -0.01$ 0.01
Diluted EPS
$ -0.07$ -0.14-$ -0.01$ -0.01$ 0.01
Basic Average Shares
$ 60.04M$ 54.98M$ 47.76M$ 47.76M$ 47.76M$ 47.66M
Diluted Average Shares
$ 60.04M$ 53.84M$ 47.76M$ 47.76M$ 47.76M$ 47.66M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 15.21M$ 8.89M$ 818.43K$ 616.29K$ 1.80M$ 7.50M
Net Income From Continuing And Discontinued Operation
$ -15.21M$ -7.70M$ -117.45K$ -371.60K$ -370.75K$ 419.66K
Normalized Income
$ -4.00M--$ -371.60K$ -370.75K$ 419.66K
Interest Expense
$ 211.00--$ 1.98K$ 2.27K$ 3.66K
EBIT
$ -15.20M$ -7.69M$ -130.46K$ -422.75K$ -441.55K$ 515.55K
EBITDA
$ -4.23M$ -42.16K$ -130.46K$ -422.75K$ -441.55K$ 515.55K
Currency in USD

Acro Biomedical Co Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis